Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros











Intervalo de año de publicación
1.
Arq Neuropsiquiatr ; 81(12): 1134-1145, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-38157879

RESUMEN

In recent decades, there have been significant advances in the diagnosis of diffuse gliomas, driven by the integration of novel technologies. These advancements have deepened our understanding of tumor oncogenesis, enabling a more refined stratification of the biological behavior of these neoplasms. This progress culminated in the fifth edition of the WHO classification of central nervous system (CNS) tumors in 2021. This comprehensive review article aims to elucidate these advances within a multidisciplinary framework, contextualized within the backdrop of the new classification. This article will explore morphologic pathology and molecular/genetics techniques (immunohistochemistry, genetic sequencing, and methylation profiling), which are pivotal in diagnosis, besides the correlation of structural neuroimaging radiophenotypes to pathology and genetics. It briefly reviews the usefulness of tractography and functional neuroimaging in surgical planning. Additionally, the article addresses the value of other functional imaging techniques such as perfusion MRI, spectroscopy, and nuclear medicine in distinguishing tumor progression from treatment-related changes. Furthermore, it discusses the advantages of evolving diagnostic techniques in classifying these tumors, as well as their limitations in terms of availability and utilization. Moreover, the expanding domains of data processing, artificial intelligence, radiomics, and radiogenomics hold great promise and may soon exert a substantial influence on glioma diagnosis. These innovative technologies have the potential to revolutionize our approach to these tumors. Ultimately, this review underscores the fundamental importance of multidisciplinary collaboration in employing recent diagnostic advancements, thereby hoping to translate them into improved quality of life and extended survival for glioma patients.


Nas últimas décadas, houve avanços significativos no diagnóstico de gliomas difusos, impulsionados pela integração de novas tecnologias. Esses avanços aprofundaram nossa compreensão da oncogênese tumoral, permitindo uma estratificação mais refinada do comportamento biológico dessas neoplasias. Esse progresso culminou na quinta edição da classificação da OMS de tumores do sistema nervoso central (SNC) em 2021. Esta revisão abrangente tem como objetivo elucidar esses avanços de forma multidisciplinar, no contexto da nova classificação. Este artigo irá explorar a patologia morfológica e as técnicas moleculares/genéticas (imuno-histoquímica, sequenciamento genético e perfil de metilação), que são fundamentais no diagnóstico, além da correlação dos radiofenótipos da neuroimagem estrutural com a patologia e a genética. Aborda sucintamente a utilidade da tractografia e da neuroimagem funcional no planejamento cirúrgico. Destacaremos o valor de outras técnicas de imagem funcional, como ressonância magnética de perfusão, espectroscopia e medicina nuclear, na distinção entre a progressão do tumor e as alterações relacionadas ao tratamento. Discutiremos as vantagens das diferentes técnicas de diagnóstico na classificação desses tumores, bem como suas limitações em termos de disponibilidade e utilização. Além disso, os crescentes avanços no processamento de dados, inteligência artificial, radiômica e radiogenômica têm grande potencial e podem em breve exercer uma influência substancial no diagnóstico de gliomas. Essas tecnologias inovadoras têm o potencial de revolucionar nossa abordagem a esses tumores. Em última análise, esta revisão destaca a importância fundamental da colaboração multidisciplinar na utilização dos recentes avanços diagnósticos, com a esperança de traduzi-los em uma melhor qualidade de vida e uma maior sobrevida.


Asunto(s)
Neoplasias Encefálicas , Neoplasias del Sistema Nervioso Central , Glioma , Humanos , Inteligencia Artificial , Calidad de Vida , Glioma/diagnóstico por imagen , Glioma/genética , Imagen por Resonancia Magnética , Neoplasias Encefálicas/diagnóstico por imagen , Neoplasias Encefálicas/genética , Neoplasias del Sistema Nervioso Central/diagnóstico por imagen
2.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;81(12): 1134-1145, Dec. 2023. tab, graf
Artículo en Inglés | LILACS-Express | LILACS | ID: biblio-1527905

RESUMEN

Abstract In recent decades, there have been significant advances in the diagnosis of diffuse gliomas, driven by the integration of novel technologies. These advancements have deepened our understanding of tumor oncogenesis, enabling a more refined stratification of the biological behavior of these neoplasms. This progress culminated in the fifth edition of the WHO classification of central nervous system (CNS) tumors in 2021. This comprehensive review article aims to elucidate these advances within a multidisciplinary framework, contextualized within the backdrop of the new classification. This article will explore morphologic pathology and molecular/genetics techniques (immunohistochemistry, genetic sequencing, and methylation profiling), which are pivotal in diagnosis, besides the correlation of structural neuroimaging radiophenotypes to pathology and genetics. It briefly reviews the usefulness of tractography and functional neuroimaging in surgical planning. Additionally, the article addresses the value of other functional imaging techniques such as perfusion MRI, spectroscopy, and nuclear medicine in distinguishing tumor progression from treatment-related changes. Furthermore, it discusses the advantages of evolving diagnostic techniques in classifying these tumors, as well as their limitations in terms of availability and utilization. Moreover, the expanding domains of data processing, artificial intelligence, radiomics, and radiogenomics hold great promise and may soon exert a substantial influence on glioma diagnosis. These innovative technologies have the potential to revolutionize our approach to these tumors. Ultimately, this review underscores the fundamental importance of multidisciplinary collaboration in employing recent diagnostic advancements, thereby hoping to translate them into improved quality of life and extended survival for glioma patients.


Resumo Nas últimas décadas, houve avanços significativos no diagnóstico de gliomas difusos, impulsionados pela integração de novas tecnologias. Esses avanços aprofundaram nossa compreensão da oncogênese tumoral, permitindo uma estratificação mais refinada do comportamento biológico dessas neoplasias. Esse progresso culminou na quinta edição da classificação da OMS de tumores do sistema nervoso central (SNC) em 2021. Esta revisão abrangente tem como objetivo elucidar esses avanços de forma multidisciplinar, no contexto da nova classificação. Este artigo irá explorar a patologia morfológica e as técnicas moleculares/genéticas (imuno-histoquímica, sequenciamento genético e perfil de metilação), que são fundamentais no diagnóstico, além da correlação dos radiofenótipos da neuroimagem estrutural com a patologia e a genética. Aborda sucintamente a utilidade da tractografia e da neuroimagem funcional no planejamento cirúrgico. Destacaremos o valor de outras técnicas de imagem funcional, como ressonância magnética de perfusão, espectroscopia e medicina nuclear, na distinção entre a progressão do tumor e as alterações relacionadas ao tratamento. Discutiremos as vantagens das diferentes técnicas de diagnóstico na classificação desses tumores, bem como suas limitações em termos de disponibilidade e utilização. Além disso, os crescentes avanços no processamento de dados, inteligência artificial, radiômica e radiogenômica têm grande potencial e podem em breve exercer uma influência substancial no diagnóstico de gliomas. Essas tecnologias inovadoras têm o potencial de revolucionar nossa abordagem a esses tumores. Em última análise, esta revisão destaca a importância fundamental da colaboração multidisciplinar na utilização dos recentes avanços diagnósticos, com a esperança de traduzi-los em uma melhor qualidade de vida e uma maior sobrevida.

3.
Knee Surg Sports Traumatol Arthrosc ; 31(11): 5207-5213, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37659012

RESUMEN

PURPOSE: Knowledge of the complex anatomy of the lateral ankle ligaments is essential to understand its function, pathophysiology and treatment options. This study aimed to assess the lateral ligaments and their relationships through a 3D view achieved by digitally marking their footprints. METHODS: Eleven fresh-frozen ankle specimens were dissected. The calcaneus, talus and fibula were separated, maintaining the lateral ligament footprints. Subsequently, each bone was assessed by a light scanner machine. Finally, all the scans were converted to 3D polygonal models. The footprint areas of the talus, calcaneus and fibula were selected, analysed and the surface area was quantified in cm2. RESULTS: After scanning the bones, the anterior talofibular ligament inferior fascicle (ATFLif), calcaneofibular ligament (CFL) and posterior talofibular ligament (PTFL) footprints were continuous at the medial side of the fibula, corresponding to a continuous footprint with a mean area of 4.8 cm2 (± 0.7). The anterior talofibular ligament (ATFL) footprint on the talus consisted of 2 parts in 9 of the 11 feet, whilst there was a continuous insertion in the other 2 feet. The CFL insertion on the calcaneus was one single footprint in all cases. CONCLUSION: The tridimensional analysis of the lateral ligaments of the ankle demonstrates that the ATFLif, CFL and PTFL have a continuous footprint at the medial side of the fibula in all analysed specimens. These data can assist the surgeon in interpreting the ligament injuries, improving the imaging assessment and guiding the surgeon to repair and reconstruct the ligaments in an anatomical position.

4.
CienciaUAT ; 17(2): 181-196, ene.-jun. 2023. tab, graf
Artículo en Español | LILACS-Express | LILACS | ID: biblio-1447828

RESUMEN

RESUMEN La evapotranspiración de referencia (ETo) es una variable hidrológica de gran importancia en el manejo del riego. Su estimación se realiza con la ecuación de Penman-Montieth (PM), que requiere de muchas variables meteorológicas, las cuales, a veces, no se encuentran disponibles. Dado que la ETo es una variable no lineal y compleja, en los últimos años han surgido métodos alternativos para su estimación, como las redes neuronales artificiales (RNA). El objetivo del presente trabajo fue estimar la evapotranspiración de referencia (ETo) usando la ecuación de Penman-Montieth, a fin de desarrollar modelos de redes neuronales artificiales (RNA) que permitan predecir la ETo en regiones con información climatológica limitada, y su vez comparar el desempeño de tres modelos de RNA: FFNN, ERNN y NARX. Se utilizó información diaria durante el periodo 1 de enero de 2007 al 31 de diciembre de 2018, de las estaciones meteorológicas ENP8 y ENP4 de la CDMX. Se realizó un análisis de correlación y el análisis de sensibilidad de Garson para estudiar 2 casos (red estática FFNN y redes dinámicas: ERNN y NARX) usando 3 modelos de RNA: 1) RNA con 6 entradas: radiación solar (Rad), temperatura máxima y mínima (Tmax, Tmin), humedad relativa máxima y mínima (HRmax, HRmin) y velocidad del viento (u); y 2) RNA con 2 entradas (Rad y Tmax). La variable de salida fue la ETo calculada con la ecuación de PM. En todos los casos, las 3 RNA fueron muy parecidas, la diferencia más notable es que las redes dinámicas (ERNN y NARX) requieren de menor número de iteraciones para llegar al desempeño óptimo. Las RNA entrenadas, únicamente con Rad y Tmax como entradas, fueron capaces de predecir la ETo en el largo plazo, durante 440 d, en otra estación meteorológica cercana (ENP4), con eficiencias mayores al 90 %.


ABSTRACT Reference evapotranspiration (ETo) is a hydrological variable of great importance in irrigation management. Its estimation is carried out with the Penman-Montieth (PM) equation that requires many meteorological variables and that are sometimes not available. Since ETo is a nonlinear and complex variable, in recent years alternative methods have emerged for its estimation, such as artificial neural networks (ANN). The objective of this work was to estimate the reference evapotranspiration (ETo) using the Penman-Montieth equation, in order to develop artificial neural network (ANN) models that allow ETo to be predicted in regions with limited climatological information, and in turn to compare the performance of three RNA models: FFNN, ERNN and NARX. Daily informtion was used during the January 1, 2007 to December 31, 2018 period, for the ENP8 and ENP4 meteorological stations in Mexico city. Based on the correlation analysis and the Garson sensitivity analysis, 2 cases were studied for the 3 ANN models: 1) ANN with 6 inputs: solar radiation (Rad), maximum and minimum temperature (Tmax, Tmin), maximum and minimum relative humidity (RHmax, RHmin), and wind speed (u), and 2) RNA with 2 inputs (Rad and Tmax). The output variable was the ETo, calculated with the PM equation. In all cases, the performance of the 3 ANNs was very similar. The most notable difference is that the dynamic networks (ERNN and NARX) require fewer iterations to achieve the optimum performance. ANNs trained only with radiation and maximum temperature as inputs were able to predict a long-term ETo for 440 at another nearby meteorological station (ENP4), with efficiencies greater than 90 %.

5.
Radiol Bras ; 56(1): 42-49, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36926353

RESUMEN

Pancreatic ductal adenocarcinoma is one of the most aggressive malignant neoplasms, with a one-year survival rate below 20%. Axial methods (computed tomography and magnetic resonance imaging) play a fundamental role in the diagnosis and staging of the disease, because they provide adequate anatomical resolution in the assessment of key structures, mainly vascular structures. Pancreatic ductal adenocarcinoma is most often discovered in advanced stages, when surgical resection is no longer feasible. In that scenario, minimally invasive treatment alternatives have been developed in attempts to change the natural history of the disease. Irreversible electroporation, an interventional procedure that minimizes deleterious effects on adjacent tissues, has proven useful for the treatment of tumors traditionally considered unresectable. Despite the growing acknowledgment of this technique as a tool for the management of pancreatic ductal adenocarcinoma, it is still relatively unknown among radiologists. In this study, we sought to provide an overview of the main characteristics and eligibility criteria that must be considered for the indication of irreversible electroporation in cases of pancreatic ductal adenocarcinoma.


O adenocarcinoma ductal de pâncreas é uma das neoplasias malignas mais agressivas, com taxas de sobrevivência anuais inferiores a 20%. Os métodos axiais (tomografia computadorizada e ressonância magnética) têm papel fundamental no diagnóstico e estadiamento da doença, por fornecerem adequada resolução anatômica na avaliação de estruturas-chave, principalmente vasculares. O adenocarcinoma ductal de pâncreas é frequentemente descoberto em estágios avançados e sem viabilidade de ressecção cirúrgica, e nesse cenário o desenvolvimento de alternativas terapêuticas minimamente invasivas tem sido ainda mais importante para a mudança de sua história natural. A eletroporação irreversível, procedimento intervencionista que minimiza efeitos deletérios nos tecidos adjacentes, vem se destacando no tratamento de lesões tradicionalmente consideradas irressecáveis. Essa técnica, apesar de ganhar cada vez mais espaço no manejo terapêutico do adenocarcinoma ductal de pâncreas, ainda é pouco familiar aos radiologistas. Neste estudo, buscamos expor, de forma sucinta e didática, os fundamentos da técnica, as principais características de imagem e os critérios de elegibilidade que devem ser considerados para indicação da eletroporação irreversível nessa doença.

6.
Radiol. bras ; Radiol. bras;56(1): 42-49, Jan.-Feb. 2023. tab, graf
Artículo en Portugués | LILACS-Express | LILACS | ID: biblio-1422525

RESUMEN

Resumo O adenocarcinoma ductal de pâncreas é uma das neoplasias malignas mais agressivas, com taxas de sobrevivência anuais inferiores a 20%. Os métodos axiais (tomografia computadorizada e ressonância magnética) têm papel fundamental no diagnóstico e estadiamento da doença, por fornecerem adequada resolução anatômica na avaliação de estruturas-chave, principalmente vasculares. O adenocarcinoma ductal de pâncreas é frequentemente descoberto em estágios avançados e sem viabilidade de ressecção cirúrgica, e nesse cenário o desenvolvimento de alternativas terapêuticas minimamente invasivas tem sido ainda mais importante para a mudança de sua história natural. A eletroporação irreversível, procedimento intervencionista que minimiza efeitos deletérios nos tecidos adjacentes, vem se destacando no tratamento de lesões tradicionalmente consideradas irressecáveis. Essa técnica, apesar de ganhar cada vez mais espaço no manejo terapêutico do adenocarcinoma ductal de pâncreas, ainda é pouco familiar aos radiologistas. Neste estudo, buscamos expor, de forma sucinta e didática, os fundamentos da técnica, as principais características de imagem e os critérios de elegibilidade que devem ser considerados para indicação da eletroporação irreversível nessa doença.


Abstract Pancreatic ductal adenocarcinoma is one of the most aggressive malignant neoplasms, with a one-year survival rate below 20%. Axial methods (computed tomography and magnetic resonance imaging) play a fundamental role in the diagnosis and staging of the disease, because they provide adequate anatomical resolution in the assessment of key structures, mainly vascular structures. Pancreatic ductal adenocarcinoma is most often discovered in advanced stages, when surgical resection is no longer feasible. In that scenario, minimally invasive treatment alternatives have been developed in attempts to change the natural history of the disease. Irreversible electroporation, an interventional procedure that minimizes deleterious effects on adjacent tissues, has proven useful for the treatment of tumors traditionally considered unresectable. Despite the growing acknowledgment of this technique as a tool for the management of pancreatic ductal adenocarcinoma, it is still relatively unknown among radiologists. In this study, we sought to provide an overview of the main characteristics and eligibility criteria that must be considered for the indication of irreversible electroporation in cases of pancreatic ductal adenocarcinoma.

7.
Ecancermedicalscience ; 17: 1638, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-38414937

RESUMEN

Purpose: Central nervous system (CNS) metastases are a significant burden in breast cancer (BC). Capecitabine is a frequent choice in this scenario, but data supporting its single-agent activity are scarce. We aimed to evaluate the intracranial efficacy of capecitabine in CNS metastases from BC. Methods: This retrospective cohort included patients with CNS metastases from BC treated with capecitabine at a single centre. Study endpoints were intracranial CNS objective response rate (CNS-ORR), intracranial CNS disease control rate (CNS-DCR), intracranial CNS progression-free survival (CNS-PFS) and overall survival (OS). Results: 209 patients were included; 41.6% hormone receptor-positive HER2-negative (HR + HER2-), 33.9% human epidermal growth factor receptor 2 positive (HER2+), and 26.4% triple-negative breast cancer (TNBC). Radiotherapy was performed in 90.4% and CNS surgery in 27.5%. Among patients accessible for intracranial response, 3-month CNS-ORR and CNS-DCR were 41.6% and 81.2%. CNS-ORR was numerically higher among TNBC (61% versus 38% in HR + HER2-BC and 35% in HER2 + BC) (p = 0.194). When considering patients who were not evaluable at 3-month as non-responders, the 3-month CNS-ORR was 19.1% (18.4% in HR + HER2-, 18.3% in HER2+, and 21.6% in TNBC). Nevertheless, TNBC was associated with lower CNS-PFS (p < 0.001) and OS (p < 0.001). Median PFS was 8.3 months in HR + HER2-, 5.0 months in HER2+, and 3.0 months in TNBC. Median OS was 8.7, 9.1 and 4.5 months, respectively. Conclusion: Among patients with BC and CNS metastases accessible for intracranial response at 3 months, intracranial activity was observed with capecitabine. These patients have a poor prognosis regardless of the BC subtype, especially in scenarios where newer therapeutic options are unavailable.

8.
Biomolecules ; 12(11)2022 11 07.
Artículo en Inglés | MEDLINE | ID: mdl-36358999

RESUMEN

Pomegranate (PMG; Punica granatum L.) fruits possess a well-balanced nutrient/phytochemical composition, with proven adjuvant benefits in experimental cancer chemotherapy; however, such bioactivity could be affected by PMG's phenogenotype (varietal). Here, the chemical and phytochemical (UPLC-DAD-MS2) composition, antioxidant capacity and anticancer potential [in vitro (MTT assay) and in silico (foodinformatics)] of three PMG fruits of different aryl color [red (cv. Wonderful), pink (cv. Molar de Elche), and white (cv. Indian)] were evaluated. The macro/micronutrient (ascorbic acid, tocols, carotenoids), organic acid (citric/malic), and polyphenol content were changed by PMG's varietal and total antioxidant activity (ABTS, alcoholic > hexane extract) in the order of red > pink > white. However, their in vitro cytotoxicity was the same (IC50 > 200 µg.mL-1) against normal (retinal) and cancer (breast, lung, colorectal) cell lines. Sixteen major phytochemicals were tentatively identified, four of them with a high GI absorption/bioavailability score [Ellagic (pink), vanillic (red), gallic (white) acids, D-(+)-catechin (white)] and three of them with multiple molecular targets [Ellagic (52) > vanillic (32) > gallic (23)] associated with anticancer (at initiation and promotion stages) activity. The anticancer potential of the PMG fruit is phenogenotype-specific, although it could be more effective in nutraceutical formulations (concentrates).


Asunto(s)
Lythraceae , Granada (Fruta) , Frutas/química , Lythraceae/química , Polifenoles/análisis , Fitoquímicos/química , Antioxidantes/química , Extractos Vegetales/química
9.
Int. braz. j. urol ; 44(3): 642-644, May-June 2018. graf
Artículo en Inglés | LILACS | ID: biblio-954048

RESUMEN

ABSTRACT Renal replacement lipomatosis is a condition characterized by varying degrees of renal parenchymal atrophy and perirenal fibrofatty proliferation secondary to chronic inflammation such as xanthogranulomatous pyelonephritis. In severe cases, imaging findings can be misdiagnosed as retroperitoneal liposarcoma.


Asunto(s)
Humanos , Masculino , Neoplasias Retroperitoneales/diagnóstico por imagen , Pielonefritis Xantogranulomatosa/diagnóstico , Enfermedades Renales/diagnóstico por imagen , Lipomatosis/diagnóstico por imagen , Liposarcoma/diagnóstico por imagen , Neoplasias Retroperitoneales/patología , Pielonefritis Xantogranulomatosa/patología , Radiografía Abdominal , Tomografía Computarizada por Rayos X , Diagnóstico Diferencial , Enfermedades Renales/patología , Lipomatosis/patología , Liposarcoma/patología , Persona de Mediana Edad
11.
Bol. latinoam. Caribe plantas med. aromát ; 13(6): 527-536, nov.2014. ilus, tab
Artículo en Inglés | LILACS | ID: lil-795823

RESUMEN

The chemical constituents of the hexane and methanol extracts obtained from the branch bark of Bursera simaruba (Burseraceae) grown in Querétaro, Mexico, were investigated by GC-MS, HPLC coupled to DAD, and NMR techniques. Seventeen compounds, including terpenoids, flavonoids, phenolic acids, long-chain fatty acids (FA), methyl esters of FA and sucrose, were identified. In addition, an assessment of the antiradical activity of the methanol extract (ME) was also carried out using DPPH, ABTS, FRAP and DPV assays. The DPPH, ABTS and FRAP assays showed a low antioxidant capacity for the ME. This was in accordance with the relatively low quantities of phenols found in the extract. However, according to the differential pulse voltammetry assay (DVP), this extract exhibited an oxidation potential close to those of quercetin and (+)-catechin, two of the flavonoids with recognized good antioxidant power. This indicated that the ME does contain compounds with good antioxidant capacity and suggested that sometimes the most popular methods commonly used might be underestimating the true antioxidant capacities of plant samples and how the DPV is a valuable complementary tool to be taken into consideration when conducting these in vitro assays...


Los constituyentes químicos de los extractos hexánicos y metanólicos de la corteza de ramas de Bursera simaruba (Burseraceae) recolectada en Querétaro, México, fueron investigados mediante las Cromatografías de Gases acoplada a Espectrometría de masas (GC-MS) y de líquidos de alta resolución (HPLC) acoplada a un detector de arreglo de diodos (DAD) (HPLC-DAD) y mediante RMN. Diecisiete compuestos, incluyendo terpenos, flavonoides, ácidos fenólicos, ácidos grasos de cadena larga (AG), ésteres metílicos de AG y la sacarosa fueron identificados. De manera adicional, se determinó la actividad antioxidante del extracto metanólico utilizando los ensayos de DPPH, ABTS, FRAP y DPV (Voltametría de Pulso Diferencial). Los métodos de DPPH, ABTS y FRAP indicaron una baja capacidad antioxidante para este extracto. Esta observación estuvo de acuerdo con las bajas cantidades de fenólicos encontrados en este extracto. Sin embargo, mediante el método DPV, el extracto tuvo un potencial de oxidación cercano a los de la quercetina y la (+)-catequina, dos de los flavonoides con reconocida buna capacidad antioxidante. Estos resultados indican que el extracto sí contiene metabolitos secundarios con buena capacidad antioxidante y sugieren además que los métodos más comunes pueden subestimar la verdadera capacidad antioxidante de extractos de plantas y resalta la importancia del método DPV como complementario a tener en cuenta en estos tipos de estudios in vitro...


Asunto(s)
Humanos , Antioxidantes/farmacología , Bursera/química , Extractos Vegetales/farmacología , Extractos Vegetales/química , Antioxidantes/química , Cromatografía Líquida de Alta Presión , Técnicas Electroquímicas , Fenoles/análisis , Cromatografía de Gases y Espectrometría de Masas , Terpenos/análisis
12.
Rev. méd. Chile ; 138(10): 1272-1275, oct. 2010. tab
Artículo en Español | LILACS | ID: lil-572939

RESUMEN

Background: Tuberculous spondylodiscitis is relatively uncommon but represents the most common location of osseous tuberculosis. Aim: To describe clinical features, imaging studies and laboratory tests to establish the diagnosis in a group of patients living in Cádiz (Spain). Material and Methods: Retrospective analysis of medical records of patients with tuberculous spondylodiscitis diagnosed between 2000 and 2009. The diagnosis was based on microorganism recovery from vertebral samples obtained by imaging guided biopsies. Results: Six patients with positive Mycobac-terium tuberculosis cultures from vertebral samples, were identified (10 percent of extra-pulmonary tuberculosis). In only 2 patients the Ziehl-Nielsen stain was positive, and histology was compatible in 4 cases. Four patients were females, their mean age was 54.3 years and the mean duration of symptoms was 7.3 months. Three patients had lumbar location and a positive Mantoux test. A soft tissue abscess was present in 4 cases. None of these patients had neurological complications. The treatment with four tuberculostatic agents (isoniazid, rifampicin, pyrazinamide and ethambutol) was effective in 5 patients. Conclusions: Tuberculous spondylodiscitis may become a serious disease due to diagnostic and treatment delays. The main examinations to establish diagnosis are magnetic resonance imaging and biopsy with microbiological culture. Generally, antituberculous therapy is effective in this clinical situation.


Asunto(s)
Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Discitis/diagnóstico , Tuberculosis de la Columna Vertebral/diagnóstico , Antituberculosos/uso terapéutico , Discitis/tratamiento farmacológico , Estudios Retrospectivos , España , Tuberculosis de la Columna Vertebral/tratamiento farmacológico
13.
Rev Med Chil ; 138(10): 1272-5, 2010 Oct.
Artículo en Español | MEDLINE | ID: mdl-21279274

RESUMEN

BACKGROUND: Tuberculous spondylodiscitis is relatively uncommon but represents the most common location of osseous tuberculosis. AIM: To describe clinical features, imaging studies and laboratory tests to establish the diagnosis in a group of patients living in Cádiz (Spain). MATERIAL AND METHODS: Retrospective analysis of medical records of patients with tuberculous spondylodiscitis diagnosed between 2000 and 2009. The diagnosis was based on microorganism recovery from vertebral samples obtained by imaging guided biopsies. RESULTS: Six patients with positive Mycobac-terium tuberculosis cultures from vertebral samples, were identified (10% of extra-pulmonary tuberculosis). In only 2 patients the Ziehl-Nielsen stain was positive, and histology was compatible in 4 cases. Four patients were females, their mean age was 54.3 years and the mean duration of symptoms was 7.3 months. Three patients had lumbar location and a positive Mantoux test. A soft tissue abscess was present in 4 cases. None of these patients had neurological complications. The treatment with four tuberculostatic agents (isoniazid, rifampicin, pyrazinamide and ethambutol) was effective in 5 patients. CONCLUSIONS: Tuberculous spondylodiscitis may become a serious disease due to diagnostic and treatment delays. The main examinations to establish diagnosis are magnetic resonance imaging and biopsy with microbiological culture. Generally, antituberculous therapy is effective in this clinical situation.


Asunto(s)
Discitis/diagnóstico , Tuberculosis de la Columna Vertebral/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Antituberculosos/uso terapéutico , Discitis/tratamiento farmacológico , Femenino , Humanos , Masculino , Estudios Retrospectivos , España , Tuberculosis de la Columna Vertebral/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA